Chronic lunotriquetral instability: diagnosis and treatment.

D. Kirschenbaum,Michael P. Coyle,J. P. Leddy

DOI: https://doi.org/10.1016/0363-5023(93)90411-U

1993-11-01

Abstract:

What problem does this paper attempt to address?

Characterizing long COVID in an international cohort: 7 months of symptoms and their impact

Hannah E. Davis,Gina S. Assaf,Lisa McCorkell,Hannah Wei,Ryan J. Low,Yochai Re'em,Signe Redfield,Jared P. Austin,Athena Akrami

DOI: https://doi.org/10.1016/j.eclinm.2021.101019

IF: 15.1

2021-08-01

EClinicalMedicine

Abstract:BackgroundA significant number of patients with COVID-19 experience prolonged symptoms, known as Long COVID. Few systematic studies have investigated this population, particularly in outpatient settings. Hence, relatively little is known about symptom makeup and severity, expected clinical course, impact on daily functioning, and return to baseline health.MethodsWe conducted an online survey of people with suspected and confirmed COVID-19, distributed via COVID-19 support groups (e.g. Body Politic, Long COVID Support Group, Long Haul COVID Fighters) and social media (e.g. Twitter, Facebook). Data were collected from September 6, 2020 to November 25, 2020. We analyzed responses from 3762 participants with confirmed (diagnostic/antibody positive; 1020) or suspected (diagnostic/antibody negative or untested; 2742) COVID-19, from 56 countries, with illness lasting over 28 days and onset prior to June 2020. We estimated the prevalence of 203 symptoms in 10 organ systems and traced 66 symptoms over seven months. We measured the impact on life, work, and return to baseline health.FindingsFor the majority of respondents (>91%), the time to recovery exceeded 35 weeks. During their illness, participants experienced an average of 55.9+/- 25.5 (mean+/-STD) symptoms, across an average of 9.1 organ systems. The most frequent symptoms after month 6 were fatigue, post-exertional malaise, and cognitive dysfunction. Symptoms varied in their prevalence over time, and we identified three symptom clusters, each with a characteristic temporal profile. 85.9% of participants (95% CI, 84.8% to 87.0%) experienced relapses, primarily triggered by exercise, physical or mental activity, and stress. 86.7% (85.6% to 92.5%) of unrecovered respondents were experiencing fatigue at the time of survey, compared to 44.7% (38.5% to 50.5%) of recovered respondents. 1700 respondents (45.2%) required a reduced work schedule compared to pre-illness, and an additional 839 (22.3%) were not working at the time of survey due to illness. Cognitive dysfunction or memory issues were common across all age groups (~88%). Except for loss of smell and taste, the prevalence and trajectory of all symptoms were similar between groups with confirmed and suspected COVID-19.InterpretationPatients with Long COVID report prolonged, multisystem involvement and significant disability. By seven months, many patients have not yet recovered (mainly from systemic and neurological/cognitive symptoms), have not returned to previous levels of work, and continue to experience significant symptom burden.FundingAll authors contributed to this work in a voluntary capacity. The cost of survey hosting (on Qualtrics) and publication fee was covered by AA's research grant (Wellcome Trust/Gatsby Charity via Sainsbury Wellcome center, UCL).
Lived experience of patients with Long COVID: a qualitative study in the UK

Callum Thomas,Mark A Faghy,Rebecca Owen,James Yates,Francesco Ferraro,Tom Bewick,Kate Haggan,Ruth E M Ashton

DOI: https://doi.org/10.1136/bmjopen-2022-068481

IF: 3.006

2023-04-26

BMJ Open

Abstract:Background: Long COVID is a rapidly evolving global health crisis requiring interdisciplinary support strategies that incorporate the lived experience of patients. Currently, there is a paucity of research documenting the day-to-day experiences of patients living with Long COVID. Objective: To explore the lived experience of Long COVID patients. Study design: Longitudinal, observation study. Setting: An inductive, data-driven, qualitative approach was used to evaluate hand-written diaries obtained from individuals who had been referred to a Derbyshire Long COVID clinic. Participants: 12 participants (11 females, age 49±10 years, 11 Caucasians) were recruited. Participants were included if they had a previous confirmed or suspected COVID-19 infection with ongoing recovery, >18 years old, understood the study requirements and provided informed consent. Method: Participants were directed to complete self-report diaries over 16 weeks. Responses were transcribed verbatim and analysed using thematic analysis. Results: Three key themes were highlighted: (1) understanding who helps patients manage symptoms, (2) daily activities and the impact on quality of life and health status and (3) the effect of turbulent and episodic symptom profiles on personal identity and recovery. Conclusions: The novel challenges presented by Long COVID are complex with varying inter-related factors that are broadly impacting functional status and quality of life. Support mechanisms must incorporate the lived experiences and foster true collaborations between health professionals, patients and researchers to improve patient outcomes. Trial registration number: NCT04649957.
A trial of dextromethorphan in parkinsonian patients with motor response complications

L. Metman,P. Blanchet,P. van den Munckhof,P. Dotto,R. Natté,T. Chase

DOI: https://doi.org/10.1002/mds.870130307

IF: 9.698

1998-05-01

Movement Disorders

Abstract:The effects of the NMDA antagonist dextromethorphan (DM) on levodopa‐associated dyskinesias and motor fluctuations were studied in patients with advanced Parkinson's disease. During initial open‐label dose escalation, 6 of 18 patients reported a beneficial effect at their individually determined optimal DM dose (range, 60–120 mg/day). The 12 remaining patients either experinced reversible side effects, particularly mild drowsiness, or decreased levodopa efficacy, and were therefore excluded from the study. The six responders entered the double‐blind, placebo‐controlled, crossover study with two 2‐week arms separted by 1 week wash‐out. On the last day of each arm, motor ratings were performed every 20 minutes for 8 consecutive hours. In addition, motor complications and Activities of Daily Living (ADL) were assessed using the Unified Parkinson's Disease Rating Scale (UPDRS) and patient diaries. With DM, dyskinesias improved by 25% according to physician's ratings and by 40% accfording to UPDRS interviews, without compromising the anti‐Parkinson effect of levodopa. Motor fluctuations and ADL scores also improved significantly. Although the narrow therapeutic index of DM limits its clinical usefulness, these findings support the view that drugs acting to inhibit glutamatergic transmission at the NMDA receptor can ameliorate levodopa‐associated motor complications.
Attributes and predictors of long COVID

Carole H. Sudre,Benjamin Murray,Thomas Varsavsky,Mark S. Graham,Rose S. Penfold,Ruth C. Bowyer,Joan Capdevila Pujol,Kerstin Klaser,Michela Antonelli,Liane S. Canas,Erika Molteni,Marc Modat,M. Jorge Cardoso,Anna May,Sajaysurya Ganesh,Richard Davies,Long H. Nguyen,David A. Drew,Christina M. Astley,Amit D. Joshi,Jordi Merino,Neli Tsereteli,Tove Fall,Maria F. Gomez,Emma L. Duncan,Cristina Menni,Frances M. K. Williams,Paul W. Franks,Andrew T. Chan,Jonathan Wolf,Sebastien Ourselin,Tim Spector,Claire J. Steves

DOI: https://doi.org/10.1038/s41591-021-01292-y

IF: 82.9

2021-03-10

Nature Medicine

Abstract:Reports of long-lasting coronavirus disease 2019 (COVID-19) symptoms, the so-called 'long COVID', are rising but little is known about prevalence, risk factors or whether it is possible to predict a protracted course early in the disease. We analyzed data from 4,182 incident cases of COVID-19 in which individuals self-reported their symptoms prospectively in the COVID Symptom Study app<sup><a href="/articles/s41591-021-01292-y#ref-CR1">1</a></sup>. A total of 558 (13.3%) participants reported symptoms lasting ≥28 days, 189 (4.5%) for ≥8 weeks and 95 (2.3%) for ≥12 weeks. Long COVID was characterized by symptoms of fatigue, headache, dyspnea and anosmia and was more likely with increasing age and body mass index and female sex. Experiencing more than five symptoms during the first week of illness was associated with long COVID (odds ratio = 3.53 (2.76–4.50)). A simple model to distinguish between short COVID and long COVID at 7 days (total sample size, <i>n</i> = 2,149) showed an area under the curve of the receiver operating characteristic curve of 76%, with replication in an independent sample of 2,472 individuals who were positive for severe acute respiratory syndrome coronavirus 2. This model could be used to identify individuals at risk of long COVID for trials of prevention or treatment and to plan education and rehabilitation services.

biochemistry & molecular biology,cell biology,medicine, research & experimental
Exploring the perceptions and experiences of community rehabilitation for Long COVID from the perspectives of Scottish general practitioners' and people living with Long COVID: a qualitative study

Kay Cooper,Edward Duncan,Erin Hart-Winks,Julie Cowie,Joanna Shim,Emma Stage,Tricia Tooman,Lyndsay Alexander,Alison Love,Jacqui H Morris,Jane Ormerod,Jenny Preston,Paul Swinton

DOI: https://doi.org/10.1136/bmjopen-2023-082830

IF: 3.006

2024-05-15

BMJ Open

Abstract:Objectives: To explore the experience of accessing Long COVID community rehabilitation from the perspectives of people with Long COVID and general practitioners (GPs). Design: Qualitative descriptive study employing one-to-one semistructured virtual interviews analysed using the framework method. Setting: Four National Health Service Scotland territorial health boards. Participants: 11 people with Long COVID (1 male, 10 female; aged 40-65 (mean 53) and 13 GPs (5 male, 8 female). Results: Four key themes were identified: (1) The lived experience of Long COVID, describing the negative impact of Long COVID on participants' health and quality of life; (2) The challenges of an emergent and complex chronic condition, including uncertainties related to diagnosis and management; (3) Systemic challenges for Long COVID service delivery, including lack of clear pathways for access and referral, siloed services, limited resource and a perceived lack of holistic care, and (4) Perceptions and experiences of Long COVID and its management, including rehabilitation. In this theme, a lack of knowledge by GPs and people with Long COVID on the potential role of community rehabilitation for Long COVID was identified. Having prior knowledge of rehabilitation or being a healthcare professional appeared to facilitate access to community rehabilitation. Finally, people with Long COVID who had received rehabilitation had generally found it beneficial. Conclusions: There are several patient, GP and service-level barriers to accessing community rehabilitation for Long COVID. There is a need for greater understanding by the public, GPs and other potential referrers of the role of community rehabilitation professionals in the management of Long COVID. There is also a need for community rehabilitation services to be well promoted and accessible to the people with Long COVID for whom they may be appropriate. The findings of this study can be used by those (re)designing community rehabilitation services for people with Long COVID.
Personalised longitudinal symptom tracking for Long COVID in Northern Ireland

Delargy,K.,Carlisle,R.,Chaudhuri,N.,Chaudhuri,N.

DOI: https://doi.org/10.1183/13993003.congress-2024.pa4367

IF: 24.3

2024-11-01

European Respiratory Journal

Abstract:Introduction: The underlying mechanisms and factors contributing to Long COVID are poorly understood. A wide variety of symptoms have been reported several months after infection by COVID-19, including breathlessness, fatigue, brain fog and many more. Methods: During the early phase of the pandemic, we sought to investigate whether a mobile application (TIYGA ecosystem) could be used to capture data about the type, intensity (scale 1-10), and frequency of specific symptoms. We aimed to understand how to record the sequence of occurrence of new symptoms over time. Results: Thirteen participants volunteered from a Charity-led Respiratory Support Group. All participants signed a consent form and created anonymised accounts. The symptoms and interventions tracked by the app were individually personalised and chosen by the participants. There was a high burden of symptoms spanning multiple organ systems, the commonest presented in Figure 1A. The app (TIYGA ecosystem) tracked individual patient's symptoms and provided healthcare professionals (HCPs) with data regarding severity and resolution of symptoms over time (Figure 1B). Conclusion: The app (TIYGA ecosystem) allows individualised monitoring on a longitudinal basis giving HCPs a rapid overview of progress and detail about changing specific symptom prevalence. This ecosystem provides a unique digital interface that may enhance communication between patients and HCPs.

respiratory system
Living with Long COVID: A Longitudinal Interview Study of Individuals' Communicative Resilience Through the "Long Haul"

Charee M Thompson,Sara Babu,Emily Gerlikovski,Maeve McGuire,Shana Makos,Annalisa Ranallo,Isabella Robieson

DOI: https://doi.org/10.1080/10410236.2023.2257941

Abstract:It is estimated that there are 65 million people globally - 19 million U.S. adults alone - who have long COVID, or persistent symptoms and conditions that continue or develop after an initial SARS-CoV-2 infection. Amidst their suffering and the ambiguity surrounding their health, people with long COVID engage processes of reintegrating from disruptions brought upon by their COVID-19 infection and its fallout, as well as the pandemic writ large. This process is communicative resilience (Buzzanell, 2010, 2017, 2019), and the purpose of this study is to document the experiences of people with long COVID as they sensemake, adapt, and transform their lives through communication. We employed longitudinal interviewing during the middle stages of the pandemic (Summer 2021 to Summer 2022), talking to 19 people with long COVID over the course of one year (five interviews each; 89 total interviews). Grounded in the six processes of communicative resilience, findings center the temporal and dialectic nature of resilience, with throughlines of grief, patience, and hope set against a tumultuous sociopolitical backdrop. Findings of this study have implications for how resilience is studied across time; how people learn to live with chronic illnesses; and how to support people living with long COVID and those who provide them care.
Baseline Characteristics in the Remote Diet Intervention to REduce long-COVID Symptoms Trial (ReDIRECT)

Laura Haag,Janice Richardson,Caroline Haig,Yvonne Cunningham,Heather Fraser,Naomi Brosnahan,Tracy Ibbotson,Jane Ormerod,Chris White,Emma McIntosh,Kate O'Donnell,Naveed Sattar,Alex McConnachie,Mike Lean,David Blane,Emilie Combet

DOI: https://doi.org/10.3310/nihropenres.13522.1

2024-03-05

Abstract:Background: The persistence of symptoms for ≥12 weeks after a COVID-19 infection is known as Long COVID (LC), a condition with unclear pathophysiology and no proven treatments to date. Living with obesity is a risk factor for LC and has symptoms which may overlap with and aggravate LC. Methods: ReDIRECT is a remotely delivered trial assessing whether weight management can reduce LC symptoms. We recruited people with LC and BMI >27kg/m 2. The intervention was delivered remotely by dietitians, with online data collection (medical and dietary history, COVID-19 infection and vaccination, body composition, LC history/symptoms, blood pressure, quality of life, sociodemographic data). Participants self-selected the dominant LC symptoms they most wanted to improve from the intervention. Results: Participants (n=234) in England (64%) and Scotland (30%) were mainly women (85%) of white ethnicity (90%), with 13% living in the 20% most deprived areas, a mean age of 46 (SD10) years, and median BMI of 35kg/m 2 (IQR 32-40). Before starting the study, 30% reported more than one COVID-19 infection (82% confirmed with one or more positive tests). LC Diagnosis was mainly by GPs (71%), other healthcare professionals (9%), or self-diagnosed (21%). The median total number of symptoms was 6 (IQR 4-8). Self-selected dominant LC symptoms included fatigue (54%), breathlessness (16%), pain (12%), anxiety/depression (1%) and "other" (17%). At baseline, 82% were taking medication, 57% reported 1+ other medical conditions. Quality of life was poor; 20% were on long-term sick leave or reduced working hours. Most (92%) reported having gained weight since contracting COVID-19 (median weight change +11.5 kg, range -11.5 to +45.3 kg). Conclusions: Symptoms linked to LC and overweight are diverse and complex. Remote trial delivery enabled rapid recruitment across the UK yet certain groups (e.g. men and those from ethnic minority groups) were under-represented. Trial registration: ISRCTN registry ( ISRCTN12595520, 25/11/2021).
Impact of long COVID on health-related quality-of-life: an OpenSAFELY population cohort study using patient-reported outcome measures (OpenPROMPT)

Oliver Carlile,Andrew Briggs,Alasdair D Henderson,Ben F C Butler-Cole,John Tazare,Laurie A Tomlinson,Michael Marks,Mark Jit,Liang-Yu Lin,Chris Bates,John Parry,Sebastian C J Bacon,Iain Dillingham,William A Dennison,Ruth E Costello,Alex J Walker,William Hulme,Ben Goldacre,Amir Mehrkar,Brian MacKenna,OpenSAFELY Collaborative,Emily Herrett,Rosalind M Eggo,Alex Walker,Amelia Green,Andrea Schaffer,Andrew Brown,Ben Butler-Cole,Caroline Morton,Caroline Walters,Catherine Stables,Christine Cunningham,Christopher Wood,Colm Andrews,David Evans,George Hickman,Helen Curtis,Henry Drysdale,Jessica Morley,Jon Massey,Linda Nab,Lisa Hopcroft,Louis Fisher,Lucy Bridges,Milan Wiedemann,Nicholas DeVito,Orla Macdonald,Peter Inglesby,Rebecca Smith,Richard Croker,Robin Park,Rose Higgins,Sebastian Bacon,Simon Davy,Steven Maude,Thomas O'Dwyer,Tom Ward,Victoria Speed,Liam Hart,Pete Stokes,Krishnan Bhaskaran,Ruth Costello,Thomas Cowling,Ian Douglas,Rosalind Eggo,Stephen Evans,Harriet Forbes,Richard Grieve,Daniel Grint,Sinead Langan,Viyaasan Mahalingasivam,Kathryn Mansfield,Rohini Mathur,Helen McDonald,Edward Parker,Christopher Rentsch,Anna Schultze,Liam Smeeth,Laurie Tomlinson,Jemma Walker,Elizabeth Williamson,Kevin Wing,Angel Wong,Bang Zheng,Christopher Bates,Jonathan Cockburn,Frank Hester,Sam Harper,Shaun O'Hanlon,Alex Eavis,Richard Jarvis,Dima Avramov,Paul Griffiths,Aaron Fowles,Nasreen Parkes,Rafael Perera,David Harrison,Kamlesh Khunti,Jonathan Sterne,Jennifer Quint

DOI: https://doi.org/10.1016/j.lanepe.2024.100908

2024-04-24

Abstract:Background: Long COVID is a major problem affecting patient health, the health service, and the workforce. To optimise the design of future interventions against COVID-19, and to better plan and allocate health resources, it is critical to quantify the health and economic burden of this novel condition. We aimed to evaluate and estimate the differences in health impacts of long COVID across sociodemographic categories and quantify this in Quality-Adjusted Life-Years (QALYs), widely used measures across health systems. Methods: With the approval of NHS England, we utilised OpenPROMPT, a UK cohort study measuring the impact of long COVID on health-related quality-of-life (HRQoL). OpenPROMPT invited responses to Patient Reported Outcome Measures (PROMs) using a smartphone application and recruited between November 2022 and October 2023. We used the validated EuroQol EQ-5D questionnaire with the UK Value Set to develop disutility scores (1-utility) for respondents with and without Long COVID using linear mixed models, and we calculated subsequent Quality-Adjusted Life-Months (QALMs) for long COVID. Findings: The total OpenPROMPT cohort consisted of 7575 individuals who consented to data collection, with which we used data from 6070 participants who completed a baseline research questionnaire where 24.6% self-reported long COVID. In multivariable regressions, long COVID had a consistent impact on HRQoL, showing a higher likelihood or odds of reporting loss in quality-of-life (Odds Ratio (OR): 4.7, 95% CI: 3.72-5.93) compared with people who did not report long COVID. Reporting a disability was the largest predictor of losses of HRQoL (OR: 17.7, 95% CI: 10.37-30.33) across survey responses. Self-reported long COVID was associated with an 0.37 QALM loss. Interpretation: We found substantial impacts on quality-of-life due to long COVID, representing a major burden on patients and the health service. We highlight the need for continued support and research for long COVID, as HRQoL scores compared unfavourably to patients with conditions such as multiple sclerosis, heart failure, and renal disease. Funding: This research was supported by the National Institute for Health and Care Research (NIHR) (OpenPROMPT: COV-LT2-0073).
Characterising long COVID: a living systematic review

Melina Michelen,Lakshmi Manoharan,Natalie Elkheir,Vincent Cheng,Andrew Dagens,Claire Hastie,Margaret O'Hara,Jake Suett,Dania Dahmash,Polina Bugaeva,Ishmeala Rigby,Daniel Munblit,Eli Harriss,Amanda Burls,Carole Foote,Janet Scott,Gail Carson,Piero Olliaro,Louise Sigfrid,Charitini Stavropoulou

DOI: https://doi.org/10.1136/bmjgh-2021-005427

IF: 8.056

2021-09-01

BMJ Global Health

Abstract:Background While it is now apparent clinical sequelae (long COVID) may persist after acute COVID-19, their nature, frequency and aetiology are poorly characterised. This study aims to regularly synthesise evidence on long COVID characteristics, to help inform clinical management, rehabilitation strategies and interventional studies to improve long-term outcomes. Methods A living systematic review. Medline, CINAHL (EBSCO), Global Health (Ovid), WHO Global Research on COVID-19 database, LitCovid and Google Scholar were searched till 17 March 2021. Studies including at least 100 people with confirmed or clinically suspected COVID-19 at 12 weeks or more post onset were included. Risk of bias was assessed using the tool produced by Hoy et al . Results were analysed using descriptive statistics and meta-analyses to estimate prevalence. Results A total of 39 studies were included: 32 cohort, 6 cross-sectional and 1 case–control. Most showed high or moderate risk of bias. None were set in low-income countries and few included children. Studies reported on 10 951 people (48% female) in 12 countries. Most included previously hospitalised people (78%, 8520/10 951). The longest mean follow-up time was 221.7 (SD: 10.9) days post COVID-19 onset. Over 60 physical and psychological signs and symptoms with wide prevalence were reported, most commonly weakness (41%; 95% CI 25% to 59%), general malaise (33%; 95% CI 15% to 57%), fatigue (31%; 95% CI 24% to 39%), concentration impairment (26%; 95% CI 21% to 32%) and breathlessness (25%; 95% CI 18% to 34%). 37% (95% CI 18% to 60%) of patients reported reduced quality of life; 26% (10/39) of studies presented evidence of reduced pulmonary function. Conclusion Long COVID is a complex condition with prolonged heterogeneous symptoms. The nature of studies precludes a precise case definition or risk evaluation. There is an urgent need for prospective, robust, standardised, controlled studies into aetiology, risk factors and biomarkers to characterise long COVID in different at-risk populations and settings. PROSPERO registration number CRD42020211131.

public, environmental & occupational health
Physiological presentation and risk factors of long COVID in the UK using smartphones and wearable devices: a longitudinal, citizen science, case-control study

Callum Stewart,Yatharth Ranjan,Pauline Conde,Shaoxiong Sun,Yuezhou Zhang,Zulqarnain Rashid,Heet Sankesara,Nicholas Cummins,Petroula Laiou,Xi Bai,Richard J B Dobson,Amos A Folarin

DOI: https://doi.org/10.1016/S2589-7500(24)00140-7

Abstract:Background: The emergence of long COVID as a COVID-19 sequela was largely syndromic in characterisation. Digital health technologies such as wearable devices open the possibility to study this condition with passive, objective data in addition to self-reported symptoms. We aimed to quantify the prevalence and severity of symptoms across collected mobile health metrics over 12 weeks following COVID-19 diagnosis and to identify risk factors for the development of post-COVID-19 condition (also known as long COVID). Methods: The Covid Collab study was a longitudinal, self-enrolled, community, case-control study. We recruited participants from the UK through a smartphone app, media publications, and promotion within the Fitbit app between Aug 28, 2020, and May 31, 2021. Adults (aged ≥18 years) who reported a COVID-19 diagnosis with a positive antigen or PCR test before Feb 1, 2022, were eligible for inclusion. We compared a cohort of 1200 patients who tested positive for COVID-19 with a cohort of 3600 sex-matched and age-matched controls without a COVID-19 diagnosis. Participants could provide information on COVID-19 symptoms and mental health through self-reported questionnaires (active data) and commercial wearable fitness devices (passive data). Data were compared between cohorts at three periods following diagnosis: acute COVID-19 (0-4 weeks), ongoing COVID-19 (4-12 weeks), and post-COVID-19 (12-16 weeks). We assessed sociodemographic and mobile health risk factors for the development of long COVID (defined as either a persistent change in a physiological signal or self-reported symptoms for ≥12 weeks after COVID-19 diagnosis). Findings: By Aug 1, 2022, 17 667 participants had enrolled into the study, of whom 1200 (6·8%) cases and 3600 (20·4%) controls were included in the analyses. Compared with baseline (65 beats per min), resting heart rate increased significantly during the acute (0·47 beats per min; odds ratio [OR] 1·06 [95% CI 1·03-1·09]; p<0·0001), ongoing (0·99 beats per min; 1·11 [1·08-1·14]; p<0·0001), and post-COVID-19 (0·52 beats per min; 1·04 [1·02-1·07]; p=0·0017) phases. An increased level of historical activity in the period from 24 months to 6 months preceding COVID-19 diagnosis was protective against long COVID (coefficient -0·017 [95% CI -0·030 to -0·003]; p=0·015). Depressive symptoms were persistently elevated following COVID-19 (OR 1·03 [95% CI 1·01-1·06]; p=0·0033) and were a potential risk factor for developing long COVID (1·14 [1·07-1·22]; p<0·0001). Interpretation: Mobile health technologies and commercial wearable devices might prove to be a useful resource for tracking recovery from COVID-19 and the prevalence of its long-term sequelae, as well as representing an abundant source of historical data. Mental wellbeing can be impacted negatively for an extended period following COVID-19. Funding: National Institute for Health and Care Research (NIHR), NIHR Maudsley Biomedical Research Centre, UK Research and Innovation, and Medical Research Council.
Exploring the Experiences of Living With the Post‐COVID Syndrome: A Qualitative Study

Michail Kalfas,Caroline Jolley,Nicholas Hart,Gerrard F. Rafferty,Emma L. Duncan,Timothy Nicholson,Mark Ashworth,Debbie Brewin,Barbara Barrett,Oliver C. Witard,Damien Ridge,Trudie Chalder

DOI: https://doi.org/10.1111/hex.14108

2024-06-21

Health Expectations

Abstract:Introduction Many people experience persistent symptoms for more than 12 weeks following SARS‐CoV‐2 infection, which is known as post‐COVID‐19 condition (PCS) or Long COVID (LC). PCS can impair people's quality of life and daily functioning. However, there is a lack of in‐depth research exploring the PCS patient journey, as well as gendered aspects of patients' experiences. Methods Nineteen semi‐structured qualitative interviews were conducted with people living with PCS in the United Kingdom (13 women, 6 men). Interviews were transcribed verbatim and analysed inductively using reflexive thematic analysis. Results Five main themes were identified: 'Symptom dismissal', 'Lack of information and support', 'Life before and after Long COVID', 'Psychological impact' and 'Acceptance'. A shift overtime to self‐management of symptoms was evident. These themes represent different stages of patients' PCS journey. Narratives indicated that women highlighted dismissal by healthcare professionals (HCPs), which was not as prominent in men's narratives. In addition, women went into more detail about the psychological impact of PCS compared to men. Conclusion Women with PCS reported symptom dismissal by HCPs, which may have delayed their diagnosis and negatively affected their well‐being. We were not able to explore the experiences of people from non‐conforming gender groups. Raising awareness of these issues among HCPs, particularly general practitioners, could improve patient care in PCS. Patient or Public Contribution Patient and public involvement consisted of people who took part in the interviews and commented on the themes' interpretation and study conclusions.

public, environmental & occupational health,health care sciences & services,health policy & services
Personalised Health Behaviour Support Programme in Adults With Post‐COVID Syndrome: A Randomised, Controlled Pilot Feasibility Trial

Matthew Armstrong,Rebecca Owen,Kristen Shirley Van Niekerk,Zoe L. Saynor

DOI: https://doi.org/10.1111/hex.70079

2024-10-28

Health Expectations

Abstract:Background We investigated whether a novel 8‐week personalised health behaviour support programme, focusing on the stability of symptoms and strategies to improve activities of daily living, was feasible and acceptable in adults with post‐COVID syndrome. Methods In this randomised, controlled, pilot feasibility trial, 32 adults with post‐COVID syndrome (continued symptoms for ≥ 12 weeks) were randomised 1:1 to receive personalised health behaviour support (self‐reported physical activity and symptom diaries, plus seven one‐to‐one remotely delivered personalised self‐management support sessions), once weekly for 8‐weeks, or usual care (referral to online 'your COVID‐19 recovery' programme). The primary outcome was the feasibility of recruiting and randomising adults with post‐COVID syndrome. The secondary outcomes were to assess the acceptability and safety of the intervention and various outcome measures. Results Of the 48 adults who expressed interest in the study, 32 (67%) were eligible and completed the baseline assessment. All 32 adults were willing to be randomised to either the personalised health behaviour support programme (n = 17) or usual care (n = 15) and 27 (age: 45 ± 12 years) adults completed follow‐up at 9 weeks. The intervention was deemed feasible, with high adherence (92% and 94% completion rates for the physical activity and symptom diaries, respectively) and excellent acceptability rates (94% 'liked the intervention a lot'). The intervention was deemed safe, with no symptom exacerbations reported. Conclusion An 8‐week personalised health behaviour support programme was feasible for adults with post‐COVID syndrome, with good adherence and acceptability rates. Early pilot data from this small sample also suggests meaningful improvements in physical activity, fatigue and respiratory symptoms. Patient or Public Contribution People living with post‐COVID syndrome were involved from the outset with the study design, review of study documentation and interpretation of the data following completion. Furthermore, several participants have supported the local dissemination of findings following the completion of the study.

public, environmental & occupational health,health care sciences & services,health policy & services
Physical, cognitive, and social triggers of symptom fluctuations in people living with long COVID: an intensive longitudinal cohort study

Darren C Greenwood,Maedeh Mansoubi,Nawar D Bakerly,Aishwarya Bhatia,Johnny Collett,Helen E Davies,Joanna Dawes,Brendan Delaney,Leisle Ezekiel,Phaedra Leveridge,Ghazala Mir,Willie Muhlhausen,Clare Rayner,Flo Read,Janet T Scott,Manoj Sivan,Ian Tucker-Bell,Himanshu Vashisht,Tomás Ward,Daryl B O'Connor,Helen Dawes,LOCOMOTION consortium,Kumaran Balasundaram,Megan Ball,Mauricio Barahona,Alexander Casson,Jonathan Clarke,Karen Cook,Rowena Cooper,Vasa Curcin,Julie Darbyshire,Simon de Lusignan,Carlos Echevarria,Sarah Elkin,Ana Belen Espinosa Gonzalez,Rachael Evans,Sophie Evans,Zacchaeus Falope,Ben Glampson,Madeline Goodwin,Trish Greenhalgh,Stephen Halpin,Juliet Harris,Will Hinton,Mike Horton,Samantha Jones,Joseph Kwon,Cassie Lee,Ashliegh Lovett,Mae Mansoubi,Victoria Masey,Harsha Master,Erik Mayer,Bernardo Meza-Torres,Ruairidh Milne,Jacqui Morris,Adam Mosley,Jordan Mullard,Daryl O'Connor,Rory O'Connor,Thomas Osborne,Amy Parkin,Stavros Petrou,Anton Pick,Denys Prociuk,Amy Rebane,Natalie Rogers,Adam B Smith,Nikki Smith,Emma Tucker,Paul Williams,Darren Winch,Conor Wood

DOI: https://doi.org/10.1016/j.lanepe.2024.101082

2024-09-20

Abstract:Background: Symptom fluctuations within and between individuals with long COVID are widely reported, but the extent to which severity varies following different types of activity and levels of exertion, and the timing of symptoms and recovery, have not previously been quantified. We aimed to characterise timing, severity, and nature of symptom fluctuations in response to effortful physical, social and cognitive activities, using Ecological Momentary Assessments. Methods: We recorded activity, effort, and severity of 8 core symptoms every 3 h for up to 24 days, in cohorts from both clinic and community settings. Symptom severities were jointly modelled using autoregressive and moving average processes. Findings: Consent was received from 376 participants providing ≥1 week's measurements (273 clinic-based, 103 community-based). Severity of all symptoms was elevated 30 min after all categories of activity. Increased effort was associated with increased symptom severity. Fatigue severity scores increased by 1.8/10 (95% CI: 1.6-1.9) following the highest physical exertions and by 1.5 (1.4-1.7) following cognitive efforts. There was evidence of only mild delayed fatigue 3 h (0.3, 0.2-0.5) or one day later (0.2, 0.0- 0.5). Fatigue severity increased as the day progressed (1.4, 1.0-1.7), and cognitive dysfunction was 0.2 lower at weekends (0.1-0.3). Interpretation: Cognitive, social, self-care and physical activities all triggered increased severity across every symptom, consistent with associated common pathways as potential therapeutic targets. Clear patterns of symptom fluctuations emerged that support more targeted self-management. Funding: National Institute for Health and Care Research.
Long COVID symptoms and demographic associations: A retrospective case series study using healthcare application data

David Sunkersing,Henry Goodfellow,Yi Mu,Mel Ramasawmy,Mayur Murali,Lawrence Adams,Ted J FitzGerald,Ann Blandford,Fiona Stevenson,Julia Bindman,Chris Robson,Amitava Banerjee

DOI: https://doi.org/10.1177/20542704241274292

2024-08-28

JRSM Open

Abstract:Objectives: To investigate long COVID (LC) symptoms self-reported via a digital application. Explore associations between various demographic factors and intensity of LC symptoms. Design: A retrospective case series study. We analysed self-reported symptoms from 1008 individuals with LC between November 30, 2020, and March 23, 2022. Setting: England and Wales. Participants: Individuals with LC using the healthcare application in 31 post-COVID-19 clinics and self-reporting LC symptoms. Main outcome measures: Highest reported LC symptoms, associations with demographic factors and intensity of symptoms. Results: 109 symptom categories were identified, with pain (26.5%), neuropsychological issues (18.4%), fatigue (14.3%) and dyspnoea (7.4%) the most prevalent. The intensity of reported symptoms increased by 3.3% per month since registration. Age groups 68-77 and 78-87 experienced higher symptom intensity (32.8% and 86% higher, respectively) compared to the 18-27 age group. Women reported 9.2% more intense symptoms than men, and non-white individuals with LC reported 23.5% more intense symptoms than white individuals with LC. Higher education levels (national vocational qualification (NVQ) 3 to NVQ 5) were associated with less symptom intensity (27.7%, 62.8% and 44.7% less, respectively) compared to the least educated (NVQ 1-2). People in less deprived areas had less intense symptoms than those in the most deprived area. No significant association was found between index of multiple deprivation (IMD) decile and number of symptoms. Conclusion: Treatment plans must prioritise addressing prevalent LC symptoms; we recommend sustained support for LC clinics. Demographic factors significantly influence symptom severity, underlining the need for targeted interventions. These findings can inform healthcare policies to better manage LC.
Hospitals' Strategies for Orchestrating Selection of Physician Preference Items

K. Montgomery,E. Schneller

DOI: https://doi.org/10.1111/j.1468-0009.2007.00489.x

2007-06-01

Milbank Quarterly

Abstract:This article analyzes hospitals' strategies to shape physicians' behavior and counter suppliers' power in purchasing physician preference items. Two models of standardization are limitations on the range of manufacturers or products (the "formulary" model) and price ceilings for particular item categories (the "payment-cap" model), both requiring processes to define product equivalencies often with inadequate product comparison data. The formulary model is more difficult to implement because of physicians' resistance to top-down dictates. The payment-cap model is more feasible because it preserves physicians' choice while also restraining manufacturers' power. Hospitals may influence physicians' involvement through a process of orchestration that includes committing to improve clinical facilities, scheduling, and training and fostering a culture of mutual trust and respect.
Identifying the needs of people with long COVID: a qualitative study in the UK

Amy Miller,Ning Song,Manoj Sivan,Rumana Chowdhury,Melanie Rose Burke

DOI: https://doi.org/10.1136/bmjopen-2023-082728

IF: 3.006

2024-06-21

BMJ Open

Abstract:Objectives To identify the needs of people with long COVID (LC) in the UK. Design Qualitative study using the Framework Analysis to analyse focus group discussions. Participants 25 adults with LC aged 19–76 years including 17 men and 8 women. Average disease duration was 80.1 weeks. Setting Eight focus groups were conducted in April 2023 online and in-person at the University of Leeds (UoL), UK. Recruitment routes included advertisement via Leeds Community Healthcare services, the English National Opera Breathe Programme and within the UoL. Results Three key themes/needs were identified. (Theme 1) Support systems including community groups, disability benefits, clinical services and employment support should be accessible and tailored to the needs of people with LC. (Theme 2) Research should investigate the physiology of symptoms, new clinical tests and treatment interventions to improve clinical understanding of the condition and symptom management. (Theme 3) Societal awareness should be promoted via local and national initiatives to educate the public about the condition and reduce stigma. Conclusions Participants experienced varied and individual challenges to daily life due to LC. There is a need for government acknowledgement of LC as a disability to ensure people with LC have access to disability support and legal protection. Policy development should be patient-driven and acknowledge the individual needs of people with LC in order to improve their quality of life.

medicine, general & internal
A mixed-methods analysis of the implementation of a new community long-COVID service during the 2020 pandemic: learning from practice.

Stefanie L Williams,Emily L Beadle,Paul Wiliams,Harsha Master,Annalisa L Casarin

DOI: https://doi.org/10.1101/2024.10.25.24316101

2024-10-29

Abstract:Introduction: The rapidly increasing prevalence of long-COVID (LC), the multisystem complexity of the condition and high patient symptom burden, necessitated an immediate need to develop new clinics for assessment and management. This article reports on the rapid implementation of a reactive and responsive LC care pathway. We mapped patients’ journey through this pathway, identifying the services that were activated according to prevalent symptoms, and assessed the barriers and facilitators to its implementation and delivery, from the perspective of health care professionals (HCPs) and LC patients using the Theoretical Domains Framework (TDF). Methods: Mixed methods study, including retrospective quantitative cross-sectional analysis of patient data and semi-structured qualitative interviews. One hundred and sixteen patients who attended long-COVID clinic in Hertfordshire, UK, in the first 5 months of its existence, consented for their data to be analysed for the quantitative study. Six HCPs and five patients participated in semi-structured interviews. Results: Patients were referred into the service an average of 5.75 months post initial COVID-19 infection. 82% of patients required onward referral to other HCPs, most commonly pulmonary rehabilitation, chronic fatigue specialists, and the specialist COVID-19 Rehab general practitioner embedded within the service. Patients reported having rehabilitation needs, moderate depression and anxiety, and difficulties performing usual activities of daily living at point of care. The TDF domains most relevant to the implementation of the LC pathway were beliefs about capabilities, environmental context and resources, knowledge, and reinforcement. Discussion: Our study provides novel insight into the development of a reactive multidisciplinary care pathway. Key drivers for successful implementation of LC services were identified, such as leadership, multidisciplinary teamwork, transferable skills, and knowledge exchange. Barriers to rapid set up of the service included funding constraints and the rapid evolution of an emergency context.
Long Covid: Online patient narratives, public health communication and vaccine hesitancy

Esperanza Miyake,Sam Martin

DOI: https://doi.org/10.1177/20552076211059649

2021-01-01

Digital Health

Abstract:Introduction This study combines quantitative and qualitative analyses of social media data collected through three key stages of the pandemic, to highlight the following: ‘First wave’ (March to May, 2020): negative consequences arising from a disconnect between official health communications, and unofficial Long Covid sufferers’ narratives online. ‘Second wave’ (October 2020 to January 2021): closing the ‘gap’ between official health communications and unofficial patient narratives, leading to a better integration between patient voice, research and services. ‘Vaccination phase’ (January 2021, early stages of the vaccination programme in the UK): continuing and new emerging concerns. Methods We adopted a mixed methods approach involving quantitative and qualitative analyses of 1.38 million posts mentioning long-term symptoms of Covid-19, gathered across social media and news platforms between 1 January 2020 and 1 January 2021, on Twitter, Facebook, Blogs, and Forums. Our inductive thematic analysis was informed by our discourse analysis of words, and sentiment analysis of hashtags and emojis. Results Results indicate that the negative impacts arise mostly from conflicting definitions of Covid-19 and fears around the Covid-19 vaccine for Long Covid sufferers. Key areas of concern are: time/duration; symptoms/testing; emotional impact; lack of support and resources. Conclusions Whilst Covid-19 is a global issue, specific sociocultural, political and economic contexts mean patients experience Long Covid at a localised level, needing appropriate localised responses. This can only happen if we build a knowledge base that begins with the patient, ultimately informing treatment and rehabilitation strategies for Long Covid.
An exploration of the experiences and self-generated strategies used when navigating everyday life with Long Covid

Fiona J. Leggat,Celayne Heaton-Shrestha,Jessica Fish,Aloysius Niroshan Siriwardena,Anne Domeney,Carol Rowe,Ian Patel,Judith Parsons,John Blair,Fiona Jones

DOI: https://doi.org/10.1186/s12889-024-18267-6

IF: 4.5

2024-03-13

BMC Public Health

Abstract:Abstract Background Around one in ten people who contract Covid-19 report ongoing symptoms or ‘Long Covid’. Without any known interventions to cure the condition, forms of self-management are routinely prescribed by healthcare professionals and described by people with the condition. However, there is limited research exploring what strategies are used to navigate everyday life with Long Covid, and experiences that initiate development of these strategies. Our study aimed to explore the range and influence of self-generated strategies used by people with Long Covid to navigate everyday life within the context of their own condition. Methods Forming part of the Long Covid Personalised Self-managemenT support co-design and EvaluatioN (LISTEN) project, we conducted a qualitative study using narrative interviews with adults who were not hospitalised with Covid-19. Participants aged over 18 years, who self-identified with Long Covid, were recruited from England and Wales. Data were analysed with patient contributors using a reflexive thematic analysis. Results Eighteen participants (mean age = 44 years, SD = 13 years) took part in interviews held between December 2021 and February 2022. Themes were constructed which depicted 1) the landscape behind the Long Covid experience and 2) the everyday experience of participants’ Long Covid. The everyday experience comprised a combination of physical, emotional, and social factors, forming three sub-themes: centrality of physical symptoms, navigating ‘experts’ and the ‘true colour’ of personal communities, and a rollercoaster of psychological ambiguity ). The third theme, personal strategies to manage everyday life was constructed from participants’ unique presentations and self-generated solutions to manage everyday life. This comprised five sub-themes: seeking reassurance and knowledge, developing greater self-awareness through monitoring, trial and error of ‘safe’ ideas, building in pleasure and comfort, and prioritising ‘me’ . Conclusions Among this sample of adults with Long Covid, their experiences highlighted the unpredictable nature of the condition but also the use of creative and wide ranging self-generated strategies. The results offer people with Long Covid, and healthcare professionals supporting them, an overview of the collective evidence relating to individuals' self-management which can enable ways to live ‘better’ and regain some sense of identity whilst facing the impact of a debilitating, episodic condition. Trial registration LISTEN ISRCTN36407216.

public, environmental & occupational health

Chronic lunotriquetral instability: diagnosis and treatment.

Characterizing long COVID in an international cohort: 7 months of symptoms and their impact

Lived experience of patients with Long COVID: a qualitative study in the UK

A trial of dextromethorphan in parkinsonian patients with motor response complications

Attributes and predictors of long COVID

Exploring the perceptions and experiences of community rehabilitation for Long COVID from the perspectives of Scottish general practitioners' and people living with Long COVID: a qualitative study

Personalised longitudinal symptom tracking for Long COVID in Northern Ireland

Living with Long COVID: A Longitudinal Interview Study of Individuals' Communicative Resilience Through the "Long Haul"

Baseline Characteristics in the Remote Diet Intervention to REduce long-COVID Symptoms Trial (ReDIRECT)

Impact of long COVID on health-related quality-of-life: an OpenSAFELY population cohort study using patient-reported outcome measures (OpenPROMPT)

Characterising long COVID: a living systematic review

Physiological presentation and risk factors of long COVID in the UK using smartphones and wearable devices: a longitudinal, citizen science, case-control study

Exploring the Experiences of Living With the Post‐COVID Syndrome: A Qualitative Study

Personalised Health Behaviour Support Programme in Adults With Post‐COVID Syndrome: A Randomised, Controlled Pilot Feasibility Trial

Physical, cognitive, and social triggers of symptom fluctuations in people living with long COVID: an intensive longitudinal cohort study

Long COVID symptoms and demographic associations: A retrospective case series study using healthcare application data

Hospitals' Strategies for Orchestrating Selection of Physician Preference Items

Identifying the needs of people with long COVID: a qualitative study in the UK

A mixed-methods analysis of the implementation of a new community long-COVID service during the 2020 pandemic: learning from practice.

Long Covid: Online patient narratives, public health communication and vaccine hesitancy

An exploration of the experiences and self-generated strategies used when navigating everyday life with Long Covid